Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-001261 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
9,318
Total Value
$18,324.91
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jan 5, 2026 | Sale | 4,000 | $1.96 | $7,832.40 | 132,117 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 6, 2026 | Sale | 3,618 | $1.97 | $7,114.44 | 128,499 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 7, 2026 | Sale | 1,700 | $1.99 | $3,378.07 | 126,799 | Direct | โ | View Details |